Sunshine Biopharma Inc. financial statements
Sunshine Biopharma Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 36.31M | 10-K |
| Net income | −USD 5.98M | 10-K |
| Cash and equivalents | USD 9.12M | 10-Q |
| Total debt | USD 812.42K | EODHD |
Sunshine Biopharma Inc. financials on 6ix · Sunshine Biopharma Inc. on 6ix